US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 75.440
  • -1.460-1.90%
Close Dec 20 16:00 ET
  • 75.440
  • 0.0000.00%
Post 16:15 ET
3.79BMarket Cap31.30P/E (TTM)

About Haemonetics Company

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Company Profile

SymbolHAE
Company NameHaemonetics
Listing DateMay 10, 1991
Issue Price22.00
Founded1971
CEOMr. Christopher A. Simon
MarketNYSE
Employees3657
Fiscal Year Ends03-29
Address125 Summer Street
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-781-848-7100

Company Executives

  • Name
  • Position
  • Salary
  • Christopher A. Simon
  • Director, President and Chief Executive Officer
  • 11.55M
  • Laurie A. Miller
  • Senior Vice President and Chief Human Resources Officer
  • --
  • James C. D’Arecca
  • Executive Vice President and Chief Financial Officer
  • 3.15M
  • Maryanne Maunsell Farris
  • Vice President and Chief Accounting Officer
  • --
  • Josep L. Llorens
  • Executive Vice President, Global Manufacturing and Supply Chain
  • 2.43M
  • Michelle L. Basil
  • Executive Vice President and General Counsel
  • 3.07M
  • Ellen M. Zane
  • Chairman of the Board
  • 449.98K
  • Stewart W. Strong
  • President, Global Hospital
  • --
  • Roy Galvin
  • President, Global Plasma and Blood Center
  • --
  • Dr. Mark W. Kroll,PhD,F.A.C.C.,F.H.R.S.
  • Independent Director
  • 280.73K
  • Diane M. Bryant
  • Independent Director
  • 252.59K
  • Robert E. Abernathy
  • Independent Director
  • 295.73K
  • Charles J. Dockendorff
  • Independent Director
  • 302.98K
  • Michael J. Coyle
  • Independent Director
  • 283.73K
  • Dr. Claire Pomeroy, M.B.A.,M.D.
  • Independent Director
  • 287.31K
  • Lloyd E. Johnson
  • Independent Director
  • 283.73K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.